{'fraction_non_alphanumeric': 0.03867403314917127, 'fraction_numerical': 0.027624309392265192, 'mean_word_length': 5.661764705882353, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Treatment of obstetric and gynecologic infections, with an emphasis on beta-lactamase-producing organisms.

The ideal pharmaceutical treatment for pelvic infections in women should provide good antibacterial coverage, have proven efficacy and be associated with a good outcome in terms of fertility and organ preservation. In an open study, ticarcillin disodium/clavulanate potassium was used to treat upper genital tract infections in 91 women. The clinical success rate was 92% with outpatient-acquired pelvic inflammatory disease; 50% with tuboovarian abscess, as confirmed by ultrasound; 85% with postpartum endometritis; 88% with endometritis plus chorioamnionitis; and 90% with postoperative infection, including cesarean section. The primary adverse reaction was diarrhea, in ten patients. Among the 129 aerobes isolated, 18 (14%) were beta-lactamase positive, as were 32% (20/63) of the anaerobes.